Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7AP29 (ribosomal protein L7a pseudogene 29) is a processed pseudogene found in the human genome, related in sequence to the ribosomal protein L7a gene (RPL7A)[2][5]. Unlike functional ribosomal protein genes, RPL7AP29 does not encode a functional ribosomal protein and is not involved in the biogenesis or function of ribosomes. Pseudogenes such as RPL7AP29 have historically accumulated in the genome due to duplication or retrotransposition events but do not produce active proteins and have no documented roles as therapeutic targets, disease mechanisms, or biomarkers[2][5][8]. RPL7AP29 is distinct from the functional RPL7A gene product, which is a component of the large (60S) ribosomal subunit and plays roles in ribosomal function and protein synthesis[1][6][7]. **Key distinction:** RPL7AP29 is a **pseudogene**—not a functional protein target—and there is nothing to suggest it is misspelled, but it is *not* actionable for therapeutic intervention, drug discovery, or biomarker selection[2][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein L7a pseudogene 29 (RPL7AP29).